| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528821C Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/18/2009 | US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents |
| 08/18/2009 | US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 08/18/2009 | US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction |
| 08/13/2009 | WO2009100095A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
| 08/13/2009 | WO2009098051A1 Aryl sulfonamides as effective analgesics |
| 08/13/2009 | US20090203909 Method and apparatus for the use of [11C] Carbon Monoxide in Labeling Synthesis by Photo-Initiated Carbonylation |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203740 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/13/2009 | US20090203681 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/13/2009 | US20090200513 Ionic Liquids Containing a Sulfonate Anion |
| 08/13/2009 | CA2714398A1 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
| 08/13/2009 | CA2712582A1 Aryl sulfonamides as effective analgesics |
| 08/12/2009 | EP1874748B1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators |
| 08/12/2009 | EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 08/12/2009 | EP1399417B1 Method for producing perfluoroalkanesulfonic acid esters |
| 08/12/2009 | EP0788360B3 Boronic ester and acid compounds, synthesis and uses |
| 08/12/2009 | CN101503430A Rare earth-lithium heterobimetallic complex, synthesizing method and use thereof |
| 08/12/2009 | CN101503418A Rare earth bimetal aminate, synthesizing method and use thereof |
| 08/12/2009 | CN101502798A Nano ruthenium carbon-supported metal hydrogenating catalyst and method for producing the same |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572810 Alkene piperidine derivatives as antiviral agents |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572790 Biphenyl carboxylic amide p38 kinase inhibitors |
| 08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2305313C Acylsulfamoylbenzamides, crop protection compositions comprising them, and processes for their preparation |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009095324A1 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/06/2009 | US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 08/06/2009 | US20090197891 Use of (4-Alkylpiperazinyl)(phenyl) methanones in the treatment of alzheimer's disease |
| 08/06/2009 | CA2711995A1 Novel n-(2-amino-phenyl)-amide derivatives |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2085378A1 Perfluor alkane sulphonic acid salts |
| 08/05/2009 | EP2084127A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 08/05/2009 | EP1745010B1 Substituted cyclohexyl-1,4-diamine derivatives |
| 08/05/2009 | EP1461313B1 Human adam-10 inhibitors |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1249233B9 Npyy5 antagonists |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/05/2009 | CN100522151C Compounds for treatment of inflammation, diabetes and related disorders |
| 08/04/2009 | US7569691 Protected piperazino group-bearing organoxysilane compound and making method |
| 08/04/2009 | US7569690 Process for producing oxycarbonyl-substituted piperazine derivative |
| 08/04/2009 | US7569687 Increases yields while reducing the impurity profile of the intermediates and final product; impurities are reduced when 2 mol equivalents of pyrrolidine react with the Compound V; by-product inhibition; elimmmminate unnecessary purification steps; cost efficiency; efficiency |
| 08/04/2009 | US7569609 Treating Alzheimer's disease with 2-propylpentanoic acid (valproic acid) or salts thereof; improving the GABAA receptor responses |
| 08/04/2009 | US7569608 Pentanoic acid derivatives |
| 08/04/2009 | US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 07/30/2009 | WO2009094443A1 Difluorinated tripeptides as hcv serine protease inhibitors |
| 07/30/2009 | WO2009093471A1 Apoptosis inhibitor |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | US20090192141 Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | CN101492431A Method for preparing cinepazide maleate |
| 07/29/2009 | CN101492430A Method for preparing high-purity cetirizine hydrochloride |
| 07/29/2009 | CN101492383A Process for making chiral 1,4-disubstituted piperazines |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/28/2009 | US7566803 Vitamin D receptor modulators |
| 07/28/2009 | US7566717 Substituted heterocyclic compounds |
| 07/28/2009 | US7566715 Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system |
| 07/28/2009 | CA2315235C Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | WO2009071678A3 Morpholine derivatives as antiobesity agents |
| 07/23/2009 | US20090186920 Sulfonamides as orexin antagonists |
| 07/23/2009 | US20090186829 Nitrosation-Inducible Inhibitors Biological Macromolecules |
| 07/23/2009 | DE102008003826A1 Korrosionsinhibitoren mit erhöhter biologischer Abbaubarkeit und verminderter Toxizität Corrosion inhibitors having increased biodegradability and reduced toxicity |
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/22/2009 | EP2079719A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 07/22/2009 | EP2079718A1 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia, and water by means of distillation |
| 07/22/2009 | EP2079717A1 Method for the continuous separation of mixtures comprising morpholine (mo), monoaminodiglycol (adg), ammonia, and water by means of distillation |
| 07/22/2009 | EP2079678A2 Selective tr-beta 1 agonist |
| 07/22/2009 | EP1644337B1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 07/22/2009 | EP1625112B1 Novel compounds for treatment of obesity |
| 07/22/2009 | CN101490024A Substituted phenyl acetic acids as DP-2 antagonists |
| 07/22/2009 | CN101486689A DPP-IV inhibitor with sulfonamide formamide piperazine structure |
| 07/22/2009 | CN101486688A DPP-IV inhibitor with sulfonyl amine acyl alkyl piperazine structure |
| 07/22/2009 | CN101486687A Preparation technique of setastine hydrochloride |
| 07/22/2009 | CN100516055C Preparation method of 3-(4-chlorphenyl)-3-(3,4-dialkoxyphenyl)acryloyl morpholine |
| 07/21/2009 | USRE40861 4-Trimethylammonium-3-(nonylcarbamoyl)-aminobutyrate; hypoglycemic agents; antidiabetic agents; antiischemic agents; congestive heart failure; obesity |
| 07/21/2009 | US7563896 Process of obtaining type II dehydroquinase enzyme inhibitors and precursors thereof |
| 07/21/2009 | US7563822 active ingredient a 5-amidino-2-hydroxybenzenesulfonamide derivative or a pharmaceutical acceptable salt thereof; excellent inhibitory effect on mesangial cell proliferation and decreasing effect on urine protein excretion |
| 07/21/2009 | US7563795 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | WO2009086728A1 Mothed for preparing repaglinide |
| 07/16/2009 | WO2007101007A8 Aryl sulfonyl heterocycles |
| 07/16/2009 | US20090182145 Process for preparing carboxylic acid derivatives |
| 07/16/2009 | US20090182141 Process for the preparation of sulfamide derivatives |
| 07/16/2009 | US20090182006 Treating a respiratory disorder by administering a hydrate of Gemifloxacinwith a carrier or excipient; chemical resistance; humidity; storage stability; thermodynamics; materials handling; sksin disorders; soft tissue-targeted therapy; sexual disorders; bovine mastitis; veterinary medicine |
| 07/16/2009 | US20090181971 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/15/2009 | EP2077990A1 Method for the continuous separation by distillation of mixtures that contain morpholine (mo), monoaminodiglycol (adg), ammonia and water |